Advertisement

Parathyroid-induced angiogenesis is VEGF-dependent

      Abstract

      Background. Autotransplantation of parathyroid tissue after parathyroidectomy is successful at salvaging parathyroid function. The relatively high success of parathyroid transplantation is thought to be due, in part, to the ability of parathyroid tissue to induce angiogenesis and thus recruit a new vasculature. Vascular endothelial growth factor (VEGF) is a potent angiogenic factor produced by a number of tumors and hypoxic tissues. Using a 3-dimensional intact microvessel angiogenesis system, we evaluated the role of VEGF in the stimulation of angiogenesis by human parathyroid cells. Methods. Freshly isolated rat microvessels embedded in a 3-dimensional collagen I matrix were treated with healthy 1-mm3 fragments of human parathyroid tissue or isolated parathyroid cells. Other gels were supplemented with VEGF165 or FLT-1 soluble receptor fusion protein to bind VEGF. After 11 days in culture, the gels were stained with Gs-1 lectin, a marker for rat endothelium, and linear growth of the microvessels was determined by using image analysis. Parathyroid production of VEGF was determined with reverse transcriptase-polymerase chain reaction. Results. A significant increase in microvessel growth was seen in parathyroid coculture (8.4 ± 1.0 mm) versus VEGF165 supplemented gels (6.2 ± 0.3 mm, P <.01). VEGF165 significantly augmented parathyroid-stimulated angiogenesis (13.7 ± 2.4 mm, P <.05 vs parathyroid alone). Using quantitative reverse transcriptase-polymerase chain reaction, we identified VEGF messenger RNA (mRNA) induction within 1 hour of parathyroid explant, with a 12-fold increase by 24 hours. Treatment of parathyroid cocultures with 0.2 μg/mL FLT-1 soluble receptor protein completely eliminated the parathyroid induction of angiogenesis. Conclusions. Parathyroid tissue expresses low levels of VEGF mRNA, which is significantly upregulated on explantation. Furthermore, the increased VEGF expression is essential to drive parathyroid-induced angiogenesis in our model. However, our data suggests that other parathyroid-produced factors are involved in mediating parathyroid-induced angiogenesis. (Surgery 2000;128:458–64)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Breier G
        • Damert A
        • Plate KH
        • Risau W.
        Angiogenesis in embryos and ischemic diseases.
        Thromb Haemost. 1997; 78: 678-683
        • Adamis AP
        • Shima DT
        • Yeo KT
        • et al.
        Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells.
        Biochem Biophys Res Commun. 1993; 193: 631-638
        • Folkman J.
        Tumor angiogenesis.
        Adv Cancer Res. 1985; 43: 175-203
        • Gute D
        • Laughlin MH
        • Amann JF
        Regional changes in capillary supply in skeletal muscle of interval-sprint and low-intensity, endurance-trained rats.
        Microcirculation. 1994; 1: 183-193
        • Gustafsson T
        • Puntschart A
        • Kaijser L
        • et al.
        Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle.
        Am J Physiol. 1999; 276: H679-H685
        • Isner JM
        Angiogenesis for revascularization of ischaemic tissues [editorial].
        Eur Heart J. 1997; 18: 1-2
        • Luts L
        • Sundler F.
        Autotransplantation of rat parathyroid glands: a study on morphological changes.
        Transplantation. 1998; 66: 446-453
        • Fukuda K
        • Nakajima H
        • Taniguchi E
        • et al.
        Morphology and function of human benign tumors and normal thyroid tissues maintained in severe combined immunodeficient mice.
        Cancer Lett. 1998; 132: 153-158
        • Kikumori T
        • Imai T
        • Tanaka Y
        • et al.
        Parathyroid autotrans-plantation with total thyroidectomy for thyroid carcinoma: long-term follow-up of grafted parathyroid function.
        Surgery. 1999; 125: 504-508
        • Saxe AW
        Angiogenesis of human parathyroid tissue.
        Surgery. 1984; 96: 1138-1143
        • Carter WB
        • Crowell SL
        • Boswell CA
        • et al.
        Stimulation of angiogenesis by canine parathyroid tissue.
        Surgery. 1996; 120: 1089-1094
        • Detmar M
        • Brown LF
        • Schon MP
        • et al.
        Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice.
        J Invest Dermatol. 1998; 111: 1-6
        • Larcher F
        • Murillas R
        • Bolontrade M
        • et al.
        VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development.
        Oncogene. 1998; 17: 303-311
        • Takeshita S
        • Zheng LP
        • Brogi E
        • et al.
        Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.
        J Clin Invest. 1994; 93: 662-670
        • Ferrara N
        • Carver-Moore K
        • Chen H
        • et al.
        Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.
        Nature. 1996; 380: 439-442
        • Kranz A
        • Mattfeldt T
        • Waltenberger J.
        Molecular mediators of tumor angiogenesis: enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer.
        Int J Cancer. 1999; 84: 293-298
        • Wechsel HW
        • Bichler KH
        • Feil G
        • et al.
        Renal cell carcinoma: relevance of angiogenetic factors.
        Anticancer Res. 1999; 19: 1537-1540
        • Wong MP
        • Cheung N
        • Yuen ST
        • et al.
        Vascular endothelial growth factor is up-regulated in the early premalignant stage of colorectal tumour progression.
        Int J Cancer. 1999; 81: 845-850
        • Luo Z
        • Diaco M
        • Murohara T
        • et al.
        Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury.
        Ann Thorac Surg. 1997; 64: 993-998
        • Shima DT
        • Adamis AP
        • Ferrara N
        • et al.
        Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen.
        Mol Med. 1995; 1: 182-193
        • Adamis AP
        • Shima DT
        • Tolentino MJ
        • et al.
        Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.
        Arch Ophthalmol. 1996; 114: 66-71
        • Couffinhal T
        • Silver M
        • Zheng LP
        • et al.
        Mouse model of angiogenesis.
        Am J Pathol. 1998; 152: 1667-1679
        • Hoying JB
        • Boswell CA
        • Williams SK
        Angiogenic potential of microvessel fragments established in three-dimensional collagen gels.
        In Vitro Cell Dev Biol Anim. 1996; 32: 409-419
        • Dendall RL
        • Thomas KA
        Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.
        Proc Natl Acad Sci U S A. 1993; 90: 10705-10709
        • Halsted WS
        Hypoparathyreosis, status parathyreoprivus, and transplantation of the parathyroid glands.
        Am J Med Sci. 1907; 134: 1-5
        • Monchik JM
        • Bendinelli C
        • Passero Jr, MA
        • et al.
        Subcutaneous forearm transplantation of autologous parathyroid tissue in patients with renal hyperparathyroidism.
        Surgery. 1999; 126: 1152-1158
        • Wells Jr, SA
        • Gunnells JC
        • Shelburne JD
        • et al.
        Transplantation of the parathyroid glands in man: clinical indications and results.
        Surgery. 1975; 78: 34-44
        • Suri C
        • McClain J
        • Thurston G
        • et al.
        Increased vascularization in mice overexpressing angiopoietin-1.
        Science. 1998; 282: 468-471
        • Yoshiji H
        • Harris SR
        • Thorgeirsson UP
        Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells.
        Cancer Res. 1996; 57: 3924-3928
        • Grunstein J
        • Roberts WG
        • Mathieu-Costello O
        • et al.
        Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function.
        Cancer Res. 1999; 59: 1592-1598
        • Neufeld G
        • Cohen T
        • Gengrinovitch S
        • et al.
        Vascular endothelial growth factor (VEGF) and its receptors.
        FASEB J. 1999; 13: 9-22
        • Asahara T
        • Bauters C
        • Zheng LP
        • et al.
        Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo.
        Circulation. 1995; 92: II365-II371
        • Holash J
        • Maisonpierre PC
        • Compton D
        • et al.
        Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.
        Science. 1999; 284: 1994-1998
        • Asahara T
        • Chen D
        • Takahashi T
        • et al.
        Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization [see comments].
        Circ Res. 1998; 83: 233-240